ID: ALA421327

Max Phase: Preclinical

Molecular Formula: C11H17N6O5P

Molecular Weight: 344.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN1CCOP1(=O)OCCOCn1cnc2c(O)nc(N)nc21

Standard InChI:  InChI=1S/C11H17N6O5P/c1-16-2-3-21-23(16,19)22-5-4-20-7-17-6-13-8-9(17)14-11(12)15-10(8)18/h6H,2-5,7H2,1H3,(H3,12,14,15,18)

Standard InChI Key:  WFZPCAZAPRMLKU-UHFFFAOYSA-N

Associated Targets(Human)

Raji 5516 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MOLT-4F 93 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

FM3A 1296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 344.27Molecular Weight (Monoisotopic): 344.0998AlogP: 0.17#Rotatable Bonds: 6
Polar Surface Area: 137.85Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.58CX Basic pKa: 1.01CX LogP: -0.60CX LogD: -0.60
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.55Np Likeness Score: -0.51

References

1. Kumar A, Coe PL, Jones AS, Walker RT, Balzarini J, De Clercq E..  (1990)  Synthesis and biological evaluation of some cyclic phosphoramidate nucleoside derivatives.,  33  (9): [PMID:2391680] [10.1021/jm00171a009]

Source